An anonymous reader writes: The Indian Supreme Court on Monday dismissed the plea of Swiss pharma giant Novartis AG for getting its blood cancer drug Glivec patented in India.The court rejected the claims of Swiss pharma giant and said the patents would be granted only for genuine inventions. This paves the way for Indian companies to manufacture generic drugs for cancer and make it available for rest of the developing world as well.
DEAL: For $25 - Add A Second Phone Number To Your Smartphone for life! Use promo code SLASHDOT25. Also, Slashdot's Facebook page has a chat bot now. Message it for stories and more. Check out the new SourceForge HTML5 Internet speed test! ×